Blackstone (BX) and TPG (TPG) have received approval from the European Commission to acquire joint control of Hologic under the EU merger regulation, the European commission said Tuesday.
The commission said the transaction primarily involves healthcare-related products and systems.
The Commission said the deal does not raise competition concerns, as the companies do not operate in overlapping or vertically related markets.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.